Instruct: Given the title of a paper, retrieve paper titles that are cited by the given paper
Query: Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC)
Predicting breast cancer recurrence using effective classification and feature selection technique
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
Triple-negative breast cancer.
a study on prediction of breast cancer recurrence using data mining techniques .
Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
Human Breast Cancer : Correlation of Relapse and Survival with Amplification of the HER-2 lneu Oncogene
Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences.
Breast Cancer: Insights into Risk Factors, Pathogenesis, Diagnosis and Management
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Breast cancer relapse prognosis by classic and modern structures of machine learning algorithms
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
Recurrence of ameloblastoma in temporal area: primary treatment influences recurrence rate.
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Firm Valuation and the Uncertainty of Future Tax Avoidance arqus Discussion Paper No
High-Temperature Characteristics of 3-kV 4H-SiC Reverse Blocking MOSFET for High-Performance Bidirectional Switch
Guided Play: Where Curricular Goals Meet a Playful Pedagogy
Production, Manufacturing and Logistics Dynamic pricing with real-time demand learning